|Articles|August 1, 2014
- BioPharm International-08-01-2014
- Volume 27
- Issue 8
BioPharm International, August 2014 Issue (PDF)
Click the title above to open the BioPharm International August 2014 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 11 years ago
Single-Domain Antibodies for Brain Targetingover 11 years ago
Marrying Big Data with Personalized Medicineover 11 years ago
Applying GMPs to the BioPharma Supply Chainover 11 years ago
Changes and Challenges for Generic Drugsover 11 years ago
Optimizing Human Performance, Part II: A Road Worth TravelingNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
FDA Fast Tracks Innovent’s Trispecific Antibody for Multiple Myeloma
2
FDA Priority Review of Subcutaneous Lecanemab Signals Shift in Alzheimer’s Treatment Delivery
3
Industrial-Scale Cell Therapy Automation Gains Traction with New Cellares Funding
4
HanchorBio–WuXi Biologics Partnership Targets Fusion Protein Development Challenges
5